

HY-111432 · 1 mg
MedChemExpress · Cat: HY-111432
Reach 3+ verified distributors
Manufacturer product page
medchemexpress.com/ccg-232601.html
Description
CCG-232601 compound 8f is a potent and orally active Rho/MRTF/SRF transcriptional pathway inhibitor. CCG-232601 inhibits the development of Bleomycin-induced dermal fibrosis in mice. CCG-232601 has the potential for the research of antifibrotic for systemic scleroderma.







